Good morning :)
Place Order
Add to Watchlist

Jupiter Life Line Hospitals Ltd

JLHL

Jupiter Life Line Hospitals Ltd

JLHL
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,476 cr, stock is ranked 531
Moderate RiskStock is 2.37x as volatile as Nifty
1,523.202.29% (-35.70)
1,523.202.29% (-35.70)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,476 cr, stock is ranked 531
Moderate RiskStock is 2.37x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,476 cr, stock is ranked 531
Moderate RiskStock is 2.37x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
56.628.960.06%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.536.560.52%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 5 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jupiter Life Line Hospitals Ltd operates multi-specialty hospitals in India, offering over 30 specialty treatments and promoting medical tourism.

Investor Presentation

View older 

Nov 8, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue464.84490.27737.14902.961,095.481,209.91
Raw Materialssubtract83.6497.53144.54160.86191.81909.98
Power & Fuel Costsubtract16.0415.7615.6222.8423.37
Employee Costsubtract90.11100.98128.98151.50181.97
Selling & Administrative Expensessubtract126.89137.56204.55253.27308.64
Operating & Other expensessubtract63.6767.1786.25104.96125.56
Depreciation/Amortizationsubtract25.9130.7436.1638.5642.3846.44
Interest & Other Itemssubtract25.6938.9843.9442.2726.344.16
Taxes & Other Itemssubtract3.253.8525.9955.8018.8064.29
EPS5.83-0.4510.0513.5828.9328.22
DPS0.000.000.000.001.001.00
Payout ratio0.000.000.000.000.030.04

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025

Annual Report Pending

Investor Presentation

Nov 8PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Jupiter Life Line Hospitals Ltd59.328.960.06%
Max Healthcare Institute Ltd102.6812.920.13%
Apollo Hospitals Enterprise Ltd116.1414.260.22%
Fortis Healthcare Ltd89.986.300.14%

Price Comparison

Compare JLHL with any stock or ETF
Compare JLHL with any stock or ETF
JLHL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 2.78%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding40.91%12.34%4.53%8.84%33.37%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepDec '23MarJunSep4.62%3.97%4.17%6.06%8.84%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH

Growth
3.3207%1.62%0.19%52/82 (0)
SBI Multicap Fund- Direct Plan- Growth option

Growth
2.4381%1.35%0.12%37/49 (-4)
SBI Healthcare Opportunities Fund - Growth - Direct Plan

Growth
1.2025%3.64%-0.12%9/34 (+1)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 2, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 2, 2024

News & Opinions
Spotlight
Jupiter Life rallies after Q2 PAT jumps 53% YoY to Rs 51 cr

Profit before tax (PBT) increased 66.55% to Rs 68.9 crore in Q2 FY25 as compared with Rs 41.4 crore in Q2 FY24. EBITDA stood at Rs 76.6 core in Q2 FY25, registering the growth of 23.5% as compared with Rs 62 crore in Q2 FY24. EBITDA margin was 19.2% in Q2 FY25 as against 19.5% in Q2 FY24. Ankit Thakker ED & CEO, Jupiter Life Line Hospitals, said, 'We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H1FY25, up from Rs 87.7 crore in H1FY24. This growth has been driven by strong operational performance across all three hospitals, reflected in higher occupancy rates and increased ARPOB. In Q2FY25, we added 22 beds at our Pune hospital and are in the process of adding 75 new beds at our Indore hospital, which is expected to be operational by Q4FY25. We are focused on expanding the Jupiter brand, enhancing management professionalism, and increasing our footprint. With this regards, the construction of our Dombivli hospital is progressing on schedule. For our Pune hospitals, we are in the advanced stages of obtaining the necessary regulatory approvals. With the addition of these two new facilities, our total bed capacity will increase to around 2,200 beds, and we are currently identifying another location to raise our total capacity to approximately 2,500 beds.' Jupiter Life Line Hospitals is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India. Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 52.94% in the September 2024 quarter

Net profit of Jupiter Life Line Hospitals rose 52.94% to Rs 51.51 crore in the quarter ended September 2024 as against Rs 33.68 crore during the previous quarter ended September 2023. Sales rose 22.57% to Rs 322.58 crore in the quarter ended September 2024 as against Rs 263.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales322.58263.18 23 OPM %23.2523.19 - PBDT83.3052.76 58 PBT68.9142.14 64 NP51.5133.68 53 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to announce Quarterly Result

Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 17.39% in the June 2024 quarter

Net profit of Jupiter Life Line Hospitals declined 17.39% to Rs 44.61 crore in the quarter ended June 2024 as against Rs 54.00 crore during the previous quarter ended June 2023. Sales rose 18.05% to Rs 287.13 crore in the quarter ended June 2024 as against Rs 243.22 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales287.13243.22 18 OPM %22.2421.79 - PBDT71.1445.84 55 PBT60.1435.12 71 NP44.6154.00 -17 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to table results

Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live